News | Congenital Heart | January 31, 2017

Lurie Children's Patient is Youngest, Smallest to Receive 50cc SynCardia Total Artificial Heart

Born with a congenital heart defect called hypoplastic left heart syndrome, 11-year-old Jaheim Whigham received a heart transplant in 2012, but began rejecting the donor heart in 2016

Jaheim Whigham, Lurie Children's Hospital of Chicago, Syncardia 50cc Total Artificial Heart, youngest patient

At 11 years old, Jaheim Whigham (center) is the youngest and smallest patient to receive the 50cc SynCardia temporary Total Artificial Heart. (Photo: Jan Terry, Ann & Robert H. Lurie Children's Hospital of Chicago)

January 31, 2017 — To save the life of an 11-year-old boy, Ann & Robert H. Lurie Children’s Hospital of Chicago has become the first pediatric hospital in the United States to implant the 50cc SynCardia temporary Total Artificial Heart.

Jaheim Whigham is the world’s youngest and smallest person to receive the 50cc Total Artificial Heart, a smaller version of the 70cc Total Artificial Heart that received U.S. Food and Drug Administration (FDA) approval in 2004. The smaller version is designed to fit women, men of smaller stature and adolescents like Whigham.

“We had no other options but to implant Jaheim with the artificial heart,” said Carl Backer, MD, division head, Cardiovascular Surgery at Lurie Children’s and professor of surgery at Northwestern University Feinberg School of Medicine. “Since the artificial heart implant on Dec. 1, 2016, Jaheim’s other organs have recovered nicely. He keeps getting stronger and has now been listed for a heart transplant.”

Whigham was born with a congenital heart defect called hypoplastic left heart syndrome, where the heart has just one working chamber. He received his first heart transplant in 2012. However, during a routine check-up at Lurie Children’s in October 2016, tests revealed he was in heart failure because of donor heart rejection.

Whigham was immediately admitted to the hospital and treated intensively for rejection. Several weeks later, however, his other organ systems began to fail. To save his life, Lurie Children’s cardiac surgeons removed his transplanted heart and implanted the 50cc Total Artificial Heart.

“This device is actually making him a better candidate for a transplant,” said nurse Ann Mead, RN, CCU. “Many times what happens is that a patient’s body becomes quite frail because of the other organs that are involved that makes a heart transplant a greater risk. But with physical and occupational therapy and better nutrition to make him stronger, the artificial heart makes Jaheim a better candidate when a heart is available. He can already walk around and do other things he couldn’t do before he had the artificial heart.”

Similar to a heart transplant, the SynCardia Total Artificial Heart replaces both failing heart ventricles and the four heart valves, allowing Whigham’s doctors to remove his failing donor heart. Unlike a donor heart, the Total Artificial Heart cannot be rejected by the body and is readily available at SynCardia Certified Centers, allowing patients to receive a new heart without the wait.

During a press conference held by Lurie Children’s on Jan. 17, Whigham’s parents, who have lost two other children to hypoplastic left heart syndrome, expressed their gratitude for the Lurie Children’s care team and the hope the Total Artificial Heart has given them.

"It's hard for me, but when I look at Jaheim, it makes me smile and it brings me up and gives me motivation," said his mother LaKim with tears in her eyes.

"It's an amazing thing to be here and have my kid be with me every single day, and to know we have a fighting team for us is amazing," said his father Michael.

Just a few days later, Whigham was switched from the Companion 2 hospital driver, which powers his Total Artificial Heart, to the smaller Freedom portable driver, which provides greater mobility and can be worn in a backpack or shoulder bag.

In the United States, the 50cc SynCardia temporary Total Artificial Heart is an investigative device, limited by federal law to investigational use.

For more information:

Related Content

Videos | Congenital Heart | March 20, 2018
A discussion with Ami Bhatt, M.D., director of the adult...
Stem Cell Therapy May Offer Treatment for Rare Congenital Cardiac Defect
News | Congenital Heart | February 05, 2018
February 5, 2018 — Children's Hospital Los Angeles announced participation in the first-ever...
Screening for Critical Congenital Heart Disease at Birth Saves Lives
News | Congenital Heart | December 05, 2017
Infant deaths from critical congenital heart disease (CCHD) decreased more than 33 percent in eight states that...
Abbott Initiates U.S. Pivotal Study of Amplatzer Device for Patent Ductus Arteriosus
News | Congenital Heart | September 05, 2017
Abbott announced it has initiated a U.S. pivotal clinical study evaluating the safety and effectiveness of a modified...
AHA and ACC Publish New Data Dictionary for Ambulatory EHRs in Pediatric and Congenital Cardiology
News | Congenital Heart | July 19, 2017
July 19, 2017 — The American Heart Association (AHA) and the American College of Cardiology (ACC) recently published
New Multi-Center Research Effort to Focus on Early Life Origins of Heart Health
News | Congenital Heart | June 23, 2017
Heart health in children will be the focus of three closely synergistic research projects and an integrated...
Italian Boy Becomes Youngest Patient Bridged to Transplant With SynCardia Total Artificial Heart

Andrei, 12, is the world’s youngest patient to be bridged to transplant with the SynCardia Total Artificial Heart. He is pictured after his heart transplant with his surgeon, Antonio Amodeo, M.D., at Bambino Gesù Children’s Hospital in Rome, Italy. Photo courtesy of Business Wire.

News | Congenital Heart | June 22, 2017
A 12-year-old boy at Bambino Gesù Children’s Hospital in Rome, Italy, has become the world’s youngest patient to be...
pediatric cardiomyopathy, management, clinical outcomes, NIH study, Circulation Heart Failure, Children's Hospital of Michigan
News | Congenital Heart | April 04, 2017
A multi-center study done in the United States and Canada may have global applicability for families with children...
Philips, Phoenix Children's Hospital, strategic partnership, congenital heart
News | Congenital Heart | March 07, 2017
Philips and Phoenix Children’s Hospital (Arizona) announced a long-term strategic partnership with a total value of up...
congenital heart disease, CHSD, Society of Thoracic Surgeons, public reporting, parent preferences
News | Congenital Heart | January 25, 2017
Survival statistics, surgeon-specific experience and complication rates are the types of information most wanted by...
Overlay Init